Adrienne Farid's most recent trade in Century Therapeutics Inc was a trade of 552 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 09 Jun 2025 | 552 | 250,141 | - | 0.6 | 343 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 05 May 2025 | 1,024 | 250,693 | - | 0.5 | 563 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 251,717 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 10 Mar 2025 | 2,359 | 131,717 | - | 0.6 | 1,451 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 03 Feb 2025 | 1,054 | 134,076 | - | 0.8 | 822 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 04 Nov 2024 | 1,033 | 135,130 | - | 1.2 | 1,267 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.83 per share. | 05 Aug 2024 | 1,073 | 136,163 | - | 1.8 | 1,960 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 3.11 per share. | 03 May 2024 | 913 | 137,236 | - | 3.1 | 2,836 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 146,000 | 146,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 24,000 | 138,149 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 06 Mar 2024 | 30,684 | 144,833 | - | 1.0 | 31,605 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 06 Mar 2024 | 30,684 | 114,149 | - | 5.0 | 152,340 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 30,684 | 191,486 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 06 Mar 2024 | 22,831 | 136,980 | - | 1.0 | 23,516 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 5.14 per share. | 06 Mar 2024 | 22,831 | 114,149 | - | 5.1 | 117,342 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 22,831 | 168,655 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Farid Adrienne | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 485 | 222,170 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 16 Feb 2024 | 485 | 114,634 | - | 1.0 | 500 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 16 Feb 2024 | 485 | 114,149 | - | 4.9 | 2,358 | Common Stock |
| Century Therapeutics Inc | Farid Adrienne | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 05 Feb 2024 | 2,035 | 115,933 | - | 3.8 | 7,816 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.49 per share. | 05 Feb 2024 | 1,784 | 114,149 | - | 4.5 | 8,005 | Common Stock |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 131,250 | 131,250 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 96,093 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 21,875 | 117,968 | - | 0 | Common Stock | |
| Century Therapeutics Inc | Adrienne Farid | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 105,000 | 105,000 | - | - | Stock Option (right to buy) |